# Larimar Therapeutics, Inc.: Form 8-K, filed Oct 30, 2020

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: 8-K
- Filed: 2020-10-30
- Accepted by EDGAR: Oct 30, 2020, 17:02 ET
- Period: 2020-10-27
- Accession: 0001193125-20-282731
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119312520282731/d37391d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119312520282731/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119312520282731/d37391d8k.htm

Filed Oct 30, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-282731. Last ingested by Listed: Nov 13, 2026, 17:49 ET. No prices; not investment advice.
